Use of HPA-Na is provided for the manufacture of a medicament for the treatment of SEB-induced illness. Use of P-38 is provided for the manufacture of a medicament for the treatment of SEB-induced illness. Use of a protein kinase C inhibitor selected from the group consisting of H-7 and Chelerythrine is provided for the manufacture of a medicament for the treatment of SEB-induced illness.